Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia

Teerin Liewluck, Xin Ming Shen, Margherita Milone, Andrew G Engel

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Centronuclear myopathy is a pathologically diagnosed congenital myopathy. The disease genes encode proteins with membrane modulating properties (MTM1, DNM2, and BIN1) or alter excitation-contraction coupling (RYR1). Some patients also have myasthenic symptoms but electrodiagnostic and endplate studies in these are limited. A sporadic patient had fatigable weakness and a decremental EMG response. Analysis of centronuclear myopathy disease- and candidate-genes identified no mutations. Quantitative endplate electron microscopy studies revealed simplified postsynaptic regions, endplate remodeling with normal nerve terminal size, normal synaptic vesicle density, and mild acetylcholine receptor deficiency. The amplitude of the miniature endplate potential was decreased to 60% of normal. Quantal release by nerve impulse was reduced to 40% of normal due to a decreased number of releasable quanta. The safety margin of neuromuscular transmission is compromised by decreased quantal release by nerve impulse and by a reduced postsynaptic response to the released quanta.

Original languageEnglish (US)
Pages (from-to)387-395
Number of pages9
JournalNeuromuscular Disorders
Volume21
Issue number6
DOIs
StatePublished - Jun 2011

Fingerprint

Congenital Structural Myopathies
Action Potentials
Myotonia Congenita
Excitation Contraction Coupling
Synaptic Vesicles
Muscle Weakness
Cholinergic Receptors
Electron Microscopy
Safety
Mutation
Membranes
Genes
Proteins

Keywords

  • Centronuclear myopathy
  • Myasthenic syndrome
  • Neuromuscular junction
  • Synaptic vesicle cycle

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Genetics(clinical)
  • Neurology

Cite this

Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia. / Liewluck, Teerin; Shen, Xin Ming; Milone, Margherita; Engel, Andrew G.

In: Neuromuscular Disorders, Vol. 21, No. 6, 06.2011, p. 387-395.

Research output: Contribution to journalArticle

@article{93d3b2b2f32a42a2ac52d296c26a0529,
title = "Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia",
abstract = "Centronuclear myopathy is a pathologically diagnosed congenital myopathy. The disease genes encode proteins with membrane modulating properties (MTM1, DNM2, and BIN1) or alter excitation-contraction coupling (RYR1). Some patients also have myasthenic symptoms but electrodiagnostic and endplate studies in these are limited. A sporadic patient had fatigable weakness and a decremental EMG response. Analysis of centronuclear myopathy disease- and candidate-genes identified no mutations. Quantitative endplate electron microscopy studies revealed simplified postsynaptic regions, endplate remodeling with normal nerve terminal size, normal synaptic vesicle density, and mild acetylcholine receptor deficiency. The amplitude of the miniature endplate potential was decreased to 60{\%} of normal. Quantal release by nerve impulse was reduced to 40{\%} of normal due to a decreased number of releasable quanta. The safety margin of neuromuscular transmission is compromised by decreased quantal release by nerve impulse and by a reduced postsynaptic response to the released quanta.",
keywords = "Centronuclear myopathy, Myasthenic syndrome, Neuromuscular junction, Synaptic vesicle cycle",
author = "Teerin Liewluck and Shen, {Xin Ming} and Margherita Milone and Engel, {Andrew G}",
year = "2011",
month = "6",
doi = "10.1016/j.nmd.2011.03.002",
language = "English (US)",
volume = "21",
pages = "387--395",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Endplate structure and parameters of neuromuscular transmission in sporadic centronuclear myopathy associated with myasthenia

AU - Liewluck, Teerin

AU - Shen, Xin Ming

AU - Milone, Margherita

AU - Engel, Andrew G

PY - 2011/6

Y1 - 2011/6

N2 - Centronuclear myopathy is a pathologically diagnosed congenital myopathy. The disease genes encode proteins with membrane modulating properties (MTM1, DNM2, and BIN1) or alter excitation-contraction coupling (RYR1). Some patients also have myasthenic symptoms but electrodiagnostic and endplate studies in these are limited. A sporadic patient had fatigable weakness and a decremental EMG response. Analysis of centronuclear myopathy disease- and candidate-genes identified no mutations. Quantitative endplate electron microscopy studies revealed simplified postsynaptic regions, endplate remodeling with normal nerve terminal size, normal synaptic vesicle density, and mild acetylcholine receptor deficiency. The amplitude of the miniature endplate potential was decreased to 60% of normal. Quantal release by nerve impulse was reduced to 40% of normal due to a decreased number of releasable quanta. The safety margin of neuromuscular transmission is compromised by decreased quantal release by nerve impulse and by a reduced postsynaptic response to the released quanta.

AB - Centronuclear myopathy is a pathologically diagnosed congenital myopathy. The disease genes encode proteins with membrane modulating properties (MTM1, DNM2, and BIN1) or alter excitation-contraction coupling (RYR1). Some patients also have myasthenic symptoms but electrodiagnostic and endplate studies in these are limited. A sporadic patient had fatigable weakness and a decremental EMG response. Analysis of centronuclear myopathy disease- and candidate-genes identified no mutations. Quantitative endplate electron microscopy studies revealed simplified postsynaptic regions, endplate remodeling with normal nerve terminal size, normal synaptic vesicle density, and mild acetylcholine receptor deficiency. The amplitude of the miniature endplate potential was decreased to 60% of normal. Quantal release by nerve impulse was reduced to 40% of normal due to a decreased number of releasable quanta. The safety margin of neuromuscular transmission is compromised by decreased quantal release by nerve impulse and by a reduced postsynaptic response to the released quanta.

KW - Centronuclear myopathy

KW - Myasthenic syndrome

KW - Neuromuscular junction

KW - Synaptic vesicle cycle

UR - http://www.scopus.com/inward/record.url?scp=79956146325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956146325&partnerID=8YFLogxK

U2 - 10.1016/j.nmd.2011.03.002

DO - 10.1016/j.nmd.2011.03.002

M3 - Article

VL - 21

SP - 387

EP - 395

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 6

ER -